Edition:
India

Intec Pharma Ltd (NTEC.OQ)

NTEC.OQ on NASDAQ Stock Exchange Capital Market

7.00USD
19 Jan 2018
Change (% chg)

$0.25 (+3.70%)
Prev Close
$6.75
Open
$6.70
Day's High
$7.00
Day's Low
$6.70
Volume
5,788
Avg. Vol
24,429
52-wk High
$9.80
52-wk Low
$4.20

Chart for

About

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodyna... (more)

Overall

No Ratios Available.

Financials

BRIEF-Meitav Dash Investments Ltd Group Reports 7.18 Pct Passive Stake In Intec Pharma

* MEITAV DASH INVESTMENTS LTD GROUP REPORTS 7.18 PERCENT PASSIVE STAKE IN INTEC PHARMA LTD AS OF DECEMBER 31 - SEC FILING Source text: (http://bit.ly/2D867LN) Further company coverage:

08 Jan 2018

BRIEF-Intec Pharma reports Q3 earnings per share $0.40

* Intec Pharma reports third quarter 2017 operating and financial results

16 Nov 2017

BRIEF-Acuta Capital Partners reports 10.5 pct passive stake in Intec Pharma

* Acuta Capital Partners reports 10.5 pct passive stake in Intec Pharma Ltd as of Aug 31 - SEC filing Source text: (http://bit.ly/2gRgBs0) Further company coverage:

09 Sep 2017

BRIEF-Adage Capital Partners reports 6.64 pct passive stake in Intec Pharma

* Adage Capital Partners GP LLC reports 6.64 percent passive stake in Intec Pharma Ltd ‍​as of August 16 - sec filing Source text : http://bit.ly/2vvPmop Further company coverage:

25 Aug 2017

BRIEF-Intec Pharma announces pricing of $50 mln public offering of ordinary shares

* Intec Pharma announces pricing of $50.0 million public offering of ordinary shares

16 Aug 2017

BRIEF-Intec Pharma announces proposed public offering of ordinary shares

* Intec Pharma announces proposed public offering of ordinary shares

16 Aug 2017

BRIEF-Intec Pharma reports financial results for the first half of 2017​

* Intec Pharma reports financial results for the first six months of 2017

10 Aug 2017

BRIEF-Intec Pharma reports clinical results from phase I trial of accordion pill for cannabinoid therapies

* Intec Pharma reports clinical results from phase i trial of accordion pill for cannabinoid therapies

03 Aug 2017

Earnings vs. Estimates